Which classes are most associated with antibiotic-associated diarrhea and Clostridioides difficile infection beyond clindamycin?

Which classes are most associated with antibiotic-associated diarrhea and Clostridioides difficile infection beyond clindamycin?

• A. Narrow-spectrum penicillins are the main risk for C. difficile.
• B. Aminoglycosides carry the highest risk for C. difficile.
• C. Broad-spectrum agents, notably cephalosporins and fluoroquinolones.
• D. Macrolides have the highest risk for C. difficile.

Answer: (C)

Disruption of the normal gut microbiota by antibiotics is the key driver of antibiotic-associated diarrhea and C. difficile infection. When broad-spectrum antibiotics wipe out a wide range of gut bacteria, the usual colonization resistance against C. difficile collapses, allowing spores to germinate and toxin-producing strains to dominate. Among antibiotics, those with broad-spectrum activity cause the most disruption. Cephalosporins with extensive Gram-negative and anaerobic coverage and fluoroquinolones lead to substantial changes in the intestinal flora, so they are more strongly linked to C. difficile infection than narrower-spectrum agents. In contrast, antibiotics like macrolides and aminoglycosides either have less impact on the gut flora or are less exposed to the colon, so their association with C. difficile is weaker. While clindamycin is well known for high CDI risk, the question focuses on agents beyond that, where broad-spectrum cephalosporins and fluoroquinolones stand out as the most associated classes.

Disruption of the normal gut microbiota by antibiotics is the key driver of antibiotic-associated diarrhea and C. difficile infection. When broad-spectrum antibiotics wipe out a wide range of gut bacteria, the usual colonization resistance against C. difficile collapses, allowing spores to germinate and toxin-producing strains to dominate.

Among antibiotics, those with broad-spectrum activity cause the most disruption. Cephalosporins with extensive Gram-negative and anaerobic coverage and fluoroquinolones lead to substantial changes in the intestinal flora, so they are more strongly linked to C. difficile infection than narrower-spectrum agents. In contrast, antibiotics like macrolides and aminoglycosides either have less impact on the gut flora or are less exposed to the colon, so their association with C. difficile is weaker. While clindamycin is well known for high CDI risk, the question focuses on agents beyond that, where broad-spectrum cephalosporins and fluoroquinolones stand out as the most associated classes.